Inhibition of THRIL reversed the regulatory effect of TNF-α on RA FLSs, and significantly reduced the effect of TNF-α on the activity of phosphoinositide 3-kinase (PI3K) and p-AKT signaling pathways. Here, AKT1 is linked to rheumatoid arthritis.